|
|
- 2018
具核梭杆菌灌胃对大鼠肠道菌群的影响
|
Abstract:
| [1] | Zhang C, Li S, Yang L, et al. Structural modulation of gut microbiota in life-long calorie-restricted mice[J]. Nat Commun, 2013, 4:2163. doi: 10.1038/ncomms3163. |
| [2] | Kaplan CW, Lux R, Haake SK, et al. The Fusobacterium nucleatum outer membrane protein RadD is an arginine-inhibitable adhesin required for inter-species adherence and the structured architecture of multispecies biofilm[J]. Mol Microbiol, 2009, 71(1):35-47. |
| [3] | Nwizu NN, Marshall JR, Moysich K, et al. Periodontal disease and incident cancer risk among postmenopausal women: results from the Womens Health Initiative Observational Cohort[J]. Cancer Epidemiol Biomarkers Prev, 2017, 26(8):1255-1265. |
| [4] | 赵力, 李理想, 陈飞雪, 等. 枯草芽孢杆菌灌胃对小鼠肠道菌群的影响[J]. 山东大学学报(医学版), 2017,55(10):28-35. ZHAO Li, LI Lixiang, CHEN Feixue, et al. Effect of Bacillus subtilis gavage on the intestinal microbiota of mice[J]. Journal of Shandong University(Health Sciences), 2017, 55(10):28-35. |
| [5] | Stecher B, Hardt WD. The role of microbiota in infectious disease[J]. Trends Microbiol, 2008, 16(3):107-114. |
| [6] | Norman JM, Handley SA, Baldridge MT, et al. Disease-specific alterations in the enteric virome in inflammatory bowel disease[J]. Cell, 2015, 160(3):447-460. |
| [7] | Marchesi JR, Adams DH, Fava F, et al. The gut microbiota and host health: a new clinical frontier[J]. Gut, 2016, 65(2):330-339. |
| [8] | Arumugam M, Raes J, Pelletier E, et al. Enterotypes of the human gut microbiome[J]. Nature, 2011, 473(7346):174-180. |
| [9] | Tettamanti L, Gaudio RM, Cura F, et al. Prevalence of periodontal pathogens among italian patients with chronic periodontitis: a retrospective study on 2992 patients[J]. Oral Implantol(Rome), 2017, 10(1):28-36. |
| [10] | Wang HF, Li LF, Guo SH, et al. Evaluation of antibody level against Fusobacterium nucleatum in the serological diagnosis of colorectal cancer[J]. Sci Rep, 2016, 6:33440. doi: 10.1038/srep33440. |
| [11] | Edgar RC. Search and clustering orders of magnitude faster than BLAST[J]. Bioinformatics, 2010, 26(19):2460-2461. |
| [12] | Barton MK. Evidence accumulates indicating periodontal disease as a risk factor for colorectal cancer or lymphoma[J]. CA Cancer J Clin, 2017, 67(3):173-174. |
| [13] | Momen-Heravi F, Babic A, Tworoger SS, et al. Periodontal disease, tooth loss and colorectal cancer risk: results from the nurses’ health study[J]. Int J Cancer, 2017, 140(3):646-652. |
| [14] | 束蓉. 牙周病病因及治疗研究进展[J]. 上海交通大学学报(医学版), 2007,27(6):625-628. SHU Rong. Research advances in etiology and treatment of periodontal disease[J]. Journal of Shanghai Jiaotong University(Medical Science), 2007, 27(6):625-628. |
| [15] | Saygun I, Nizam N, Keskiner I, et al. Salivary infectious agents and periodontal disease status[J]. J Periodontal Res, 2011, 46(2):235-239. |
| [16] | Dethlefsen L, McFall-Ngai M, Relman DA. An ecological and evolutionary perspective on human-microbe mutualism and disease[J]. Nature, 2007, 449(7164):811-818. |
| [17] | Macpherson AJ, Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria[J]. Science, 2004, 303(5664):1662-1665. |
| [18] | Shah MS, DeSantis TZ, Weinmaier T, et al. Leveraging sequence-based faecal microbial community survey data to identify a composite biomarker for colorectal cancer[J]. Gut, 2018, 67(5):882-891. |
| [19] | Monaco CL, Gootenberg DB, Zhao G, et al. Altered virome and bacterial microbiome in human immunodeficiency virus-associated acquired immunodeficiency syndrome[J]. Cell Host Microbe, 2016, 19(3):311-322. |
| [20] | Kostic AD, Gevers D, Siljander H, et al. The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes[J]. Cell Host Microbe, 2015, 17(2):260-273. |
| [21] | Wright EK, Kamm MA, Teo SM, et al. Recent advances in characterizing the gastrointestinal microbiome in Crohn's disease: a systematic review[J]. Inflamm Bowel Dis, 2015, 21(6):1219-1228. |
| [22] | 谢莉敏, 李丹, 程秀芳, 等. 益生菌的种类及其在人体营养保健中的应用研究[J]. 安徽农业科学, 2013(17):7694-7695. XIE Limin, LI Dan, CHENG Xiufang, et al. On species and application of probiotics in human nutrition and health care [J]. Journal of Anhui Agri, 2013, 41(17):7694-7695. |
| [23] | Stecher B, Hardt WD. Mechanisms controlling pathogen colonization of the gut[J]. Curr Opin Microbiol, 2011, 14(1):82-91. |
| [24] | Levy M, Kolodziejczyk AA, Thaiss CA, et al. Dysbiosis and the immune system[J]. Nat Rev Immunol, 2017, 17(4):219-232. |
| [25] | Simren M, Barbara G, Flint HJ, et al. Intestinal microbiota in functional bowel disorders: a Rome foundation report[J]. Gut, 2013, 62(1):159-176. |
| [26] | Kabat AM, Srinivasan N, Maloy KJ. Modulation of immune development and function by intestinal microbiota[J]. Trends Immunol, 2014, 35(11):507-517. |
| [27] | Han YW, Fardini Y, Chen C, et al. Term stillbirth caused by oral Fusobacterium nucleatum[J]. Obstet Gynecol, 2010, 115(2 Pt 2):442-445. |
| [28] | Yang Y, Weng W, Peng J, et al. Fusobacterium nucleatum increases proliferation of colorectal cancer cells and tumor development in mice by activating Toll-like receptor 4 signaling to nuclear factor-kappaB, and up-regulating expression of microRNA-21[J]. Gastroenterology, 2017, 152(4):851-866. |
| [29] | Swidsinski A, Dorffel Y, Loening-Baucke V, et al. Acute appendicitis is characterised by local invasion with Fusobacterium nucleatum/necrophorum[J]. Gut, 2011, 60(1):34-40. |
| [30] | Gur C, Ibrahim Y, Isaacson B, et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack[J]. Immunity, 2015, 42(2):344-355. |
| [31] | Rubinstein MR, Wang X, Liu W, et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin[J]. Cell Host Microbe, 2013, 14(2):195-206. |
| [32] | Abed J, Emgard JE, Zamir G, et al. Fap2 mediates Fusobacterium nucleatum colorectal adenocarcinoma enrichment by binding to tumor-expressed Gal-GalNAc[J]. Cell Host Microbe, 2016, 20(2):215-225. |
| [33] | Bertrand KA, Shingala J, Evens A, et al. Periodontal disease and risk of non-Hodgkin lymphoma in the health professionals follow-up Study[J]. Int J Cancer, 2017, 140(5):1020-1026. |
| [34] | Nakajima M, Arimatsu K, Kato T, et al. Oral administration of P. gingivalis induces dysbiosis of gut microbiota and impaired barrier function leading to dissemination of enterobacteria to the liver[J]. PLoS One, 2015, 10(7):e0134234. doi:10.1371/journal.pone.0134234. |
| [35] | Han YW. Fusobacterium nucleatum: a commensal-turned pathogen[J]. Curr Opin Microbiol, 2015, 23:141-147.doi:10.1016/j.mib.2014.11.013. |
| [36] | Strauss J, Kaplan GG, Beck PL, et al. Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host[J]. Inflamm Bowel Dis, 2011, 17(9):1971-1978. |
| [37] | Nakagaki H, Sekine S, Terao Y, et al. Fusobacterium nucleatum envelope protein FomA is immunogenic and binds to the salivary statherin-derived peptide[J]. Infect Immun, 2010, 78(3):1185-1192. |
| [38] | Michaud DS, Liu Y, Meyer M, et al. Periodontal disease, tooth loss, and cancer risk in male health professionals: a prospective cohort study[J]. Lancet Oncol, 2008, 9(6):550-558. |
| [39] | Yu T, Guo F, Yu Y, et al. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy[J]. Cell, 2017, 170(3):548-563.e16. |
| [40] | Lan Y, Wang Q, Cole JR, et al. Using the RDP classifier to predict taxonomic novelty and reduce the search space for finding novel organisms[J]. PLoS One, 2012, 7(3):e32491. doi: 10.1371/journal.pone.0032491 |
| [41] | Lundberg DS, Yourstone S, Mieczkowski P, et al. Practical innovations for high-throughput amplicon sequencing[J]. Nat Methods, 2013, 10(10):999-1002. |
